RE-Stem Biotech Co., Ltd. is a biotechnology company founded by Chinese and American medical experts. It specializes in the research and development of cell therapies targeting osteoarthritis, spinal cord injury and various cancers. A well-known biotechnology enterprise in China, RE-Stem integrates scientific research and development, clinical trials and market applications.
RE-Stem’s exploration of the body’s regenerative potential originated in the 1980’s. The founder of the company, Professor Ray (Jiao) Shoushu, was among the first group of senior intellectual graduates in the medical profession after the founding of New China.
RE-Stem is one of the earliest regenerative biotechnology companies in China to develop and apply human adipose stem cells. In 2012, RE-Stem introduced adipose stem cell technology into Chinese society and made tremendous progress in the application of safety and standardized production. In order to ensure quality and safety, all processes have passed the national ISO9001:2015 quality management system certification. The adipose stem cells used in RE-Stem’s applications are of a purity higher than 95%.